The clinical and pathological features of early-onset colorectal cancer (EOCRC) differ from those of late-onset colorectal cancer (LOCRC). Our research aims to thoroughly elucidate the distinctions between them by analyzing clinical prognosis, metastatic patterns, gene expression, and genomic mutation profiles. Our deliberation will uncover latent strategies for personalized therapeutic of both EOCRC and LOCRC.
Study Type
OBSERVATIONAL
Enrollment
15,244
Patients enrolled in these 2 cohorts all received standardized treatment of colorectal cancer.
OS
overall survival
Time frame: 5 years after intervention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.